These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10487526)

  • 21. Topoisomerase II inhibitor-induced apoptosis in thymocytes and lymphoma cells.
    Kizaki H; Onishi Y
    Adv Enzyme Regul; 1997; 37():403-23. PubMed ID: 9381984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of MST/Krs and c-Jun N-terminal kinases by different signaling pathways during cytotrienin A-induced apoptosis.
    Watabe M; Kakeya H; Onose R; Osada H
    J Biol Chem; 2000 Mar; 275(12):8766-71. PubMed ID: 10722720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.
    Sehested M; Wessel I; Jensen LH; Holm B; Oliveri RS; Kenwrick S; Creighton AM; Nitiss JL; Jensen PB
    Cancer Res; 1998 Apr; 58(7):1460-8. PubMed ID: 9537249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA topoisomerase II immunostaining in human leukemia and rhabdomyosarcoma cell lines and their responses to topoisomerase II inhibitors.
    Wolverton JS; Danks MK; Granzen B; Beck WT
    Cancer Res; 1992 Aug; 52(15):4248-53. PubMed ID: 1322239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin.
    Persons DL; Yazlovitskaya EM; Cui W; Pelling JC
    Clin Cancer Res; 1999 May; 5(5):1007-14. PubMed ID: 10353733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Collateral sensitivity to the bisdioxopiperazine dexrazoxane (ICRF-187) in etoposide (VP-16)-resistant human leukemia K562 cells.
    Fattman CL; Allan WP; Hasinoff BB; Yalowich JC
    Biochem Pharmacol; 1996 Aug; 52(4):635-42. PubMed ID: 8759037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis.
    Saeki K; Kobayashi N; Inazawa Y; Zhang H; Nishitoh H; Ichijo H; Saeki K; Isemura M; Yuo A
    Biochem J; 2002 Dec; 368(Pt 3):705-20. PubMed ID: 12206715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved targeting of brain tumors using dexrazoxane rescue of topoisomerase II combined with supralethal doses of etoposide and teniposide.
    Holm B; Sehested M; Jensen PB
    Clin Cancer Res; 1998 Jun; 4(6):1367-73. PubMed ID: 9626452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response to ICRF-159 in cell lines resistant to cleavable complex-forming topoisomerase II inhibitors.
    Davies SL; Bergh J; Harris AL; Hickson ID
    Br J Cancer; 1997; 75(6):816-21. PubMed ID: 9062401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of apoptosis with the inhibition of extracellular signal-regulated protein kinase activity in the tumor necrosis factor alpha-resistant ovarian carcinoma cell line UCI 101.
    Yazlovitskaya EM; Pelling JC; Persons DL
    Mol Carcinog; 1999 May; 25(1):14-20. PubMed ID: 10331740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. JNK (c-Jun N-terminal kinase) and p38 activation in receptor-mediated and chemically-induced apoptosis of T-cells: differential requirements for caspase activation.
    MacFarlane M; Cohen GM; Dickens M
    Biochem J; 2000 May; 348 Pt 1(Pt 1):93-101. PubMed ID: 10794718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activation and enhance radiation toxicity of human mammary carcinoma cells.
    Reardon DB; Contessa JN; Mikkelsen RB; Valerie K; Amir C; Dent P; Schmidt-Ullrich RK
    Oncogene; 1999 Aug; 18(33):4756-66. PubMed ID: 10467423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of AP-1 is required for bufalin-induced apoptosis in human leukemia U937 cells.
    Watabe M; Ito K; Masuda Y; Nakajo S; Nakaya K
    Oncogene; 1998 Feb; 16(6):779-87. PubMed ID: 9488042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidative stress induces DNA fragmentation and caspase activation via the c-Jun NH2-terminal kinase pathway in H9c2 cardiac muscle cells.
    Turner NA; Xia F; Azhar G; Zhang X; Liu L; Wei JY
    J Mol Cell Cardiol; 1998 Sep; 30(9):1789-801. PubMed ID: 9769235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of c-Jun activity increases survival to cisplatin.
    Sánchez-Pérez I; Perona R
    FEBS Lett; 1999 Jun; 453(1-2):151-8. PubMed ID: 10403393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection against nitric oxide-induced apoptosis in rat mesangial cells demands mitogen-activated protein kinases and reduced glutathione.
    Sandau KB; Callsen D; Brüne B
    Mol Pharmacol; 1999 Oct; 56(4):744-51. PubMed ID: 10496957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of alpha-PAK-interacting exchange factor in the PAK1-c-Jun NH(2)-terminal kinase 1 activation and apoptosis induced by benzo[a]pyrene.
    Yoshii S; Tanaka M; Otsuki Y; Fujiyama T; Kataoka H; Arai H; Hanai H; Sugimura H
    Mol Cell Biol; 2001 Oct; 21(20):6796-807. PubMed ID: 11564864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin activates caspase-3 by a phosphatidylinositol 3'-kinase-dependent pathway.
    Godbout JP; Cengel KA; Cheng SL; Minshall C; Kelley KW; Freund GG
    Cell Signal; 1999 Jan; 11(1):15-23. PubMed ID: 10206340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3.
    Schroeter H; Spencer JP; Rice-Evans C; Williams RJ
    Biochem J; 2001 Sep; 358(Pt 3):547-57. PubMed ID: 11535118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.
    Drew L; Fine RL; Do TN; Douglas GP; Petrylak DP
    Clin Cancer Res; 2002 Dec; 8(12):3922-32. PubMed ID: 12473608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.